ADMA Biologics ADMA
$ 17.46
-2.46%
Quarterly report 2024-Q3
added 11-07-2024
ADMA Biologics Cash and Cash Equivalents 2011-2024 | ADMA
Annual Cash and Cash Equivalents ADMA Biologics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
51.4 M | 86.5 M | 51.1 M | 55.9 M | 26.8 M | 22.8 M | 43.1 M | 9.91 M | 10.4 M | 17.2 M | 26.1 M | 12.5 M | 87.8 K |
All numbers in USD currency
Indicator range from annual reports
Maximum | Minimum | Average |
---|---|---|
86.5 M | 87.8 K | 31.8 M |
Quarterly Cash and Cash Equivalents ADMA Biologics
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
86.7 M | 88.2 M | 45.3 M | 51.4 M | 74.2 M | 62.5 M | 69.2 M | 86.5 M | 34.9 M | 52.4 M | 69.5 M | 51.1 M | 34.4 M | 42.4 M | 62 M | 55.9 M | 55.9 M | 55.9 M | 55.9 M | 26.8 M | 26.8 M | 26.8 M | 26.8 M | 26.8 M | 22.8 M | 22.8 M | 22.8 M | 43.1 M | 43.1 M | 43.1 M | 43.1 M | 9.91 M | 9.91 M | 9.91 M | 9.91 M | 10.4 M | 10.4 M | 10.4 M | 10.4 M | 17.2 M | 17.2 M | 17.2 M | 17.2 M | 26.1 M | 26.1 M | 26.1 M | 26.1 M | 12.5 M | 12.5 M | 12.5 M | 12.5 M | 87.8 K | 87.8 K | 87.8 K | 87.8 K |
All numbers in USD currency
Indicator range from quarterly reporting
Maximum | Minimum | Average |
---|---|---|
88.2 M | 87.8 K | 33 M |